THIS SHARE WILL BE WORTH 3.00 IN 2009

I feel the drop is over reaction and expect a recovery over the next few day making up at least half of the loss.

this is a rubbish share why I hold on I will never know!!

Not exactly a stated recommendation to buy, but on reading the article that is the impression given.http://www.pr-inside.com/protherics-plc-corporate-and-strategic-r708336.htm

Geek - Well I have held on for this long...The slump from 40's to low 30's is in line with the market slump but it must be overdone. Then again take your pick on undervalued companies - lots to choose from.
The failure of Phase 2b Digoxin Immune Fab (DIF) didnt go down well.

Morning Transco,

Fully agree the test results did not go down well. I think many did look on the results as a total failure, but they were not fully successful which is not quite the same. The tests did result in meeting 1 of the 2 targets.
The group's chief executive Andrew Heath said the results from this small and complex study are not conclusive and added that further analysis of the full data will be required to determine the direction of the programme.
As has been said many times on this thread, many punters want almost instant success, and in the current market conditions any bad news knocks the sp more than warranted.
As you also say "It must be overdone".
Protherics is on my list of the companies for increasing exposure. just waiting till the time is right. I feel that will be when the value of Protherics as a company(especially the potential) takes over from the market view as a whole.

I have averaged down only to lose more - if only on paper.
We need good news flow but nothing expected till end of year early next.
Iwill sit tight.

This is a Pharma, with all the risks associated wiith trials - it's very much a wait and see. Some income from rattlesnake divn, so at least shareholders shouldn't see (much) dilution, unlike most other Bio's.
I've held this for a while and this Market dip is rather worse than I expected, so maybe an av dn is looming - but then maybe not. Are you L-T transco15...? I read you're none to happy (earlier posts)......so why did you buy originially?

Well I thought if the big boys were interseted in backing them so should I - I was wrong i think!

Personal view. No you were not wrong (obviously depends on the buy in price).
Just lately I have reviewed my reasons for buying into PTI. They were drug portfolio and the relevant stages, low debt, cash in bank and the management team. To me things have on the whole only got better, it's the global trend/confidence in bio/drug companies that has caused the dragging down of the sp.
Punters are looking to 'safe bets' which these days are very hard to find, with so called defensive stocks suffering as much as any.
To me Protherics are looking just as good an investment as ever.
Patience is still needed, but withing 12/18 months I am looking at an sp of at least double today's price, but obviously that is a long time in global terms which at the moment appear to have taken over.
As to the medium/long term of 5 to 10 years I have really high hopes.

Greekman, - I tend to agree - - - - Their pre-eclampsia statement was a bit mixed , but it shows the co is still forward-moving and that has to be good.
Furthermore - YES - in these Markets almost any share can be punished - that's why it's essential to hold only those with Lots of Cash (to weather out), OR with income ( esp Pharmas) and exciting stocks that are mid-way.

Big Co's are not always safe, partly because folk can get-out easily and they don't expect a huge change in sentiment whilst they are "out" - whereas small Pharmas may change dramatically....esp Upwards...following a good Trial...

I'm hoping some Normality will happen with the change in US-President and a clearing out of "old ways" etc. Here in UK, we have to wait a little more.... until GB finally gets kicked-out, he was a disaster as Chancellor and now reaps the failures of years of Labour policy of greed and envy.......er, IMHO. I suspect UKplc will be stuck like now until something turns up.

3 nice bits of news today, especially the presentation bit.

I would say we have turned the corner,,,i hope....
The charts looking good and im dipping my toe in again..

Nicely up today with med volume, sells over 3 to 1 buys with a smaller spread than of late.
Appears the offer is chasing the ask.
On a day with the market suffering, has the previous bits of news (6th) and the Seymour recommendation of being oversold filtering through.

Yes I was right for once - a nice move up - not before time though.

w o w whats going on here. Time to buy more?

And the SP finished on a high.

mmm Im not getting carried away. Market conditions are shocking right now. I suspect some buy note is being put together and being released over the weekend..
Still is going in the right direction...... but beware if you are not already in this is a dangerous punt IMHO

With the market well down on close and PTI being the second highest riser, there should be a RNS tomorrow even if is to the effect that Protherics have no idea why there has been such a 1 day rise.

Bid stories maybe? Roch had some bid news out i think - maybe its that.
Who knows?
Must retreat in the morning I would guess?

Here's your RNS guys - well done to those who had the patience to stick with it (which I did not!):

Released 18:12 13-Aug-08
Number 2944B18

Re share price rise

London, UK; Brentwood, TN, US; 13 August 2008 - Protherics PLC ("Protherics" or the "Company"), the international biopharmaceutical company focused on critical care and cancer, notes today's rise in the Company's share price and confirms it has received approaches from a number of parties interested in acquiring Protherics, which the board is considering. However, there can be no certainty that any formal offer will be made, nor as to the terms on which any offer might be made.

A further announcement will be made in due course.

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers (the "Code"), Protherics confirms that at the close of business on 12 August 2008, it has 342,159,034 ordinary shares of 2 pence each in issue and admitted to trading on the London Stock Exchange under the UK ISIN code GB00070290.